The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos

Ocular Microbiology and Immunology Group
Back to OMIG Main Page

2012 Agenda and Abstracts | < Previous | Next >

2012 OMIG Abstract 21

Efficacy of Voriconazole and Amphotericin B as Additives in
Optisol-GS Against Candida Species

N. Layer1, V. Cevallos2, B.H. Jeng1,2

1Dept. of Ophthalmology and 2Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA

Purpose: Optisol-GS is the most commonly used corneal storage medium in the United States; however, it currently does not include an antifungal additive. This study evaluates the efficacy of adding either voriconazole or amphotericin B to Optisol-GS in reducing Candida contamination of the media.

Methods: Vials of Optisol-GS were supplemented with either voriconazole at 1x, 10x, 25x, or 50x minimum inhibitory concentration (MIC) or amphotericin B at 0.25x, 0.5x, 1x, or 10x MIC. Unsupplemented control groups were also used. Isolates of C. albicans and C. glabrata were each added to a set of Optisol-GS vials. The vials were refrigerated at 4 degrees C. On days 2 and 7, 1 mL of the solution was removed and sampled for viable colony counts immediately after removal from refrigeration and after warming to room temperature for 2 hours.

Results: No benefit was observed with voriconazole supplementation to Optisol-GS against C. albicans or C. glabrata, with growth of both organisms in all voriconazole-supplemented vials. Viable counts of C. albicans were effectively reduced with supplementation of amphotericin B at all concentrations evaluated. Viable counts of C. glabrata were effectively reduced with amphotericin B supplementation at 1x and 10x MIC.

Conclusions: The addition of amphotericin B, but not voriconazole, to Optisol-GS may significantly improve activity against Candida contamination.

Disclosure: S     Richard Lindstrom/Eye Bank Association of America Research Fund, That Man May See

2012 Agenda and Abstracts | < Previous | Next >